Skip to content

    Inve Blog

    How to Analyse an FMCG Stock (Volume, Margin, Reach)

    How to analyse an FMCG stock in India: read volume vs value growth, gross margin, A&P spend and distribution reach to find real demand under the headline.

    Inve Content Team · 24 June 2026

    In May 2025, Britannia's vice-chairman Varun Berry told analysts plainly that "our endeavor always will be to get back to double digits" — that the company would aim to return to double-digit revenue growth in FY26 (Britannia Q4 FY25 concall). It sounded fine. Britannia is one of the best-run packaged-foods companies in India, and double digits was where it had lived for years. Then look at what the year actually printed: FY26 consolidated revenue of ₹18,858 crore, up 7.5% (Inve data, Q4 FY26) — single digits, not double. Inve's Promise Tracker marks that FY26 growth guidance missed (Inve data). (Illustration of how to read the numbers, not a view on the stock.)

    The point is not that Berry was wrong. It is where the year was always going to be decided, and it was not in the revenue line he was being asked about. One quarter later, on the Q1 FY26 call, the same management told analysts the truth that the headline hid: "the delta between volume and revenue will remain at about 6%, 7%, 8% for the coming 2 or 3 quarters" (Britannia Q1 FY26 concall). Read that slowly. Most of the growth was coming from price, not from more biscuits leaving the shelf — Q1 FY26 volume growth was just 2% (Inve data, Q1 FY26) against revenue up 9.8%. An FMCG company is, at its core, a machine for selling the same small things to the same people again and again, slightly more of them each year, at a slightly better price and a slightly better margin. Almost everything that matters shows up first in two numbers that the income statement deliberately blends into one: how much more stuff you sold, and how much of the growth was just charging more.

    This is how to read a fast-moving consumer goods company the way a consumer-sector analyst does: the handful of operating numbers that decide the outcome — most of them buried in the investor deck, not the P&L — what "good" looks like for each, and the one red flag that has cost patient FMCG holders years of compounding.

    A note on the boundary first. You will not audit a distribution network of five million outlets from the outside. What you can do is read the direction of volume, margin, reach and mix, and check whether management's account of demand survives its own concall.

    What actually makes money in this business?

    Strip an FMCG company down and it is not really a product business — it is a distribution and habit business. The toothpaste, the biscuit, the hair oil: these are commodities a dozen firms can make. What you are buying is a brand a billion people reach for without thinking, sitting in five million shops within arm's reach of the consumer, refilled before it runs out. The moat is the shelf and the habit, not the recipe.

    That framing fixes the first beginner error: revenue growth, on its own, tells you almost nothing. A 10% revenue print can be a company selling 10% more units (genuine, durable demand) or selling the same units at a 10% higher price (a one-time pass-through of cost inflation that reverses the moment input prices fall). These are completely different businesses wearing the same number. The whole craft of reading an FMCG company is pulling that single number apart.

    The second thing to internalise: this is a high-return, low-growth machine. A good FMCG company throws off cash because it needs little capital to grow — no order book, no project pipeline, modest factories. So it earns a high return on capital and a premium multiple, and the market punishes it savagely the moment volume growth — the truth under value — stalls. Which is why the analysis lives in the operating metrics, not the bottom line.

    Volume vs value growth: the number the headline hides

    This is the spine of the whole exercise, so start here. Value growth is reported revenue growth. Volume growth is how many more units (kilograms, packs, litres) you actually sold. The gap between them is price-and-mix — how much you raised prices, plus how much you shifted the basket toward pricier products.

    Why it matters more here than anywhere else: in FMCG, volume is demand and price is borrowed. When palm oil or cocoa or wheat spikes, every player raises prices, revenue swells, and margins look fine — but no extra consumption happened. When inflation cools, those price increases unwind, and a company that grew only on price suddenly grows on nothing. Volume is the only growth that compounds. A company posting 12% value growth on 2% volume is not a 12% grower having a good year; it is a 2% grower passing through a cost shock, and the market will treat it that way the day inflation breaks.

    Where to find it: almost never on the income statement — companies report only the blended revenue line. Volume growth lives in the investor presentation and the concall opening remarks, sometimes only when an analyst pins management down in Q&A. This is the single most important reason to read the deck and the transcript rather than the results PDF.

    What "good" looks like: mid-to-high single-digit volume growth, sustained, is the gold standard for a mature staples company; double-digit volume is exceptional. The warning sign is a persistent, widening gap between value and volume.

    Britannia is the clean teaching case. In Q1 FY26, value growth ran 9.8% on volume of just 2% — and management itself told you not to expect that gap to close soon: a 6–8% delta "for the coming 2 or 3 quarters" (Britannia Q1 FY26 concall). By Q3 FY26 the split had improved to "about half-half, 50-50… from volume and half from value" (Britannia Q3 FY26 concall), and Q4 FY26 volume recovered to "close to 5.5% upwards" (Britannia Q4 FY26 concall). The recovery is the story — but it took a year, and a reader who saw only the 7–10% revenue prints would have missed that the engine was running on price for three quarters before volume came back. Contrast Dabur, whose India business limped to ~1.5% volume growth in Q3 FY25 (Dabur Q3 FY25 concall) — the same headline-revenue camouflage, a weaker underlying engine. (Illustration, not a view on either stock.)

    Gross margin: the commodity tug-of-war

    Gross margin is revenue minus the cost of the raw materials and packaging that went into the product, as a percentage of sales. In FMCG it is the cleanest read on the raw-material cycle and on pricing power — the two forces fighting over every rupee.

    Why it matters here specifically: FMCG companies are leveraged to soft-commodity prices — wheat, palm oil, milk, cocoa, coffee, crude-linked packaging. When inputs spike, gross margin compresses unless the company can pass it on; when inputs fall, gross margin expands before the company gives the benefit back to consumers via price cuts or extra grammage. So gross margin is a real-time gauge of whether the brand has the power to defend its economics.

    Where to find it: usually derivable from the P&L (revenue minus cost of materials), and increasingly called out explicitly in the investor deck, especially in inflationary or deflationary quarters when the swing is large.

    What "good" looks like: stability through a cost cycle is the signal of pricing power; a sharp drop that management can't pass through is the signal of a weak brand. Watch the direction and the company's explanation. Britannia expanded gross margin by 530 bps year-on-year in Q3 FY26 (Inve data, Q3 FY26) as wheat and other inputs softened — a benign-deflation tailwind, not a permanent re-rating. Dabur, on the other side of the cycle, took a standalone gross-margin contraction of 240 bps in Q4 FY25 (Dabur Q4 FY25 concall) and by Q4 FY26 was flagging "inflation of roughly around 10% hitting us in a lot of portfolios" and announcing 4% price increases to defend it (Dabur Q4 FY26 concall). Same sector, opposite ends of the commodity tug-of-war. (Illustration, not a view on either stock.)

    A&P spend: the moat's maintenance bill

    Advertising and promotion (A&P) is what the company spends on marketing — TV, digital, trade promotions — usually shown as a percentage of sales. In FMCG it is not a discretionary cost; it is the maintenance capex of the brand. A consumer habit is a depreciating asset, and A&P is the spend that keeps it from decaying.

    Why it matters here: A&P is the easiest lever a management can pull to flatter a weak quarter. Cut the ad budget and operating margin jumps — but you have just stopped maintaining the moat, and the bill comes due later as share loss. So read A&P and margin together. A margin "improvement" driven by an A&P cut is a borrowing against the future; a margin held while A&P is sustained is the real thing.

    Where to find it: the investor presentation (an "A&P-to-sales" line) and the concall; rarely broken out as its own line on the statutory P&L. Tata Consumer told analysts it intends to run "the 7.5% to 8.5% ratio as we go forward" (Tata Consumer Q4 FY26 concall) — i.e. it is signalling that it will keep investing behind brands rather than starve them for short-term margin. Nestlé India, by contrast, has shifted where it spends: digital is now 51% of media spend, up from under 25% five years ago (Nestlé India Q3 FY25 concall) — the moat is the same, the channel to maintain it has moved. (Illustration, not a view on either stock.)

    Distribution reach: counting the shelves

    Distribution reach is how many retail outlets the company's products physically reach — "direct reach" (serviced by the company's own salesforce) and "total reach" (including wholesale). It is the closest thing FMCG has to an order book: more shelves, reachable, refilled, is more future demand.

    Why it matters here: in India, availability is destiny. A consumer who can't find your sachet buys the one next to it. Expanding direct reach — where the company controls placement and freshness — is one of the few genuinely durable growth levers, and it shows up in volume two to four quarters later. It is also expensive and slow, which is why a credible reach-expansion plan, executed, is a real signal.

    Where to find it: the investor presentation, almost always — outlet counts and reach are headline deck slides, not P&L items. Britannia reported direct reach of 28.7 lakh outlets and total reach of 6.5 million outlets (Britannia Q4 FY25 concall). Nestlé India, having rebuilt from the 2015 Maggi crisis (when it lost roughly a million outlets), was at 5.3 million outlets and guiding to "about 6 million outlets" (Nestlé India Q3 FY25 concall). Bikaji, a much smaller, younger snacks company, grew direct outlet reach to 335,000 and stated a long-term ambition of 500,000 (Bikaji Q3 FY26 concall) — the scale gap is the moat the incumbents hold. (Illustration, not a view on any of these stocks.)

    But reach claims deserve scepticism, because they are easy to announce and hard to verify. Britannia's "RTM 2.0" plan to scale to 100 cities and 450,000 outlets in 12–15 months, set in Q2 FY25, is marked ghosted in Inve's Promise Tracker (Inve data) — announced, then quietly dropped from the commentary. A reach target you can't see again next quarter is a slide, not a strategy.

    Rural vs urban mix and premiumisation: who's buying, and trading up?

    Two mix questions sit on top of volume, and both decide the quality of growth.

    Rural vs urban. Rural India is roughly a third of FMCG demand and far more volatile — it tracks the monsoon, crop prices and rural wages. Urban is steadier but more penetrated, so harder to grow. A company over-indexed to whichever segment is currently weak will look worse than its brands deserve, and vice versa. The mix tells you how to read a soft quarter: a rural-heavy player in a bad-monsoon year is facing a cyclical headwind, not a brand problem. Nestlé tracks this granularly — rural village coverage reached 191,000 villages with a target of further expansion (Nestlé India Q2 FY24 concall) — because rural distribution is where its next decade of volume sits.

    Premiumisation is the slow upgrade of the basket — consumers trading from a mass biscuit to a cookie, from loose tea to a premium blend. It is the highest-quality growth there is, because it lifts both volume and margin without relying on cost inflation. Where to find it: the deck, as "premium salience" or new-product contribution. Britannia called out a 310 bps rise in premium-product salience (Inve data, Q1 FY26) and that adjacencies are growing 2.7x in e-commerce (Britannia Q4 FY26 concall); Nestlé attributes around 6.5% of sales to recent innovation (Nestlé India Q3 FY25 concall). Premiumisation is the lever that lets a 2%-volume staples company still compound earnings faster than 2% — which is exactly why the market pays up for the ones that can pull it. (Illustration, not a view on these stocks.)

    Operating margin: where it all nets out

    Operating margin (OPM) is operating profit as a percentage of sales — what's left after raw materials, A&P and overheads. It is the outcome of everything above: pricing power minus commodity pressure minus the cost of maintaining the brand. Read in isolation it is nearly useless; read as the net of the forces above, it is the scorecard.

    The discipline is to never accept a margin number without asking why it moved. A margin up because gross margin expanded on cheaper inputs is borrowed from the commodity cycle. A margin up because A&P was cut is borrowed from the future. A margin up because the company premiumised the mix and held its investment is earned. Dabur's management has been explicit that it "wants to go back to our erstwhile 20% operating margin" (Dabur Q3 FY26 concall) — H1 FY26 operating margin was running around 19% (Dabur Q2 FY26 concall) — which is the right way to read a target: against the company's own structural level, not a sector average. Nestlé and Britannia operate in the high-teens-to-twenties OPM band (Inve data, FY26); a snacks company like Bikaji runs structurally lower, around 12–15% EBITDA margin (Inve data, Q3 FY26), because fried-snack economics and a younger brand simply don't carry the same pricing power yet. (Illustration, not a view on these stocks.)

    How do you value an FMCG company without overpaying?

    Here is where FMCG breaks the spreadsheet. These companies trade at price-to-earnings multiples that look absurd against their growth — 40, 50, sometimes 60 times earnings on businesses growing high single digits. The instinct is to call them overpriced. Sometimes that's right; often it misunderstands what the multiple is paying for.

    The reason the market pays up: a great FMCG franchise is a near-perpetuity. It needs little capital, earns a high return on what it uses, and — if the brand and distribution hold — keeps compounding modestly for decades. In a discounted-cash-flow model, that profile makes the valuation terminal-value-heavy: the bulk of the worth sits in cash flows ten, twenty, thirty years out, which is precisely why a small change in the long-term volume-growth and terminal-margin assumption swings the fair value enormously. The P/E premium is, in plain terms, a bet on durability — that people will still reach for this brand a generation from now.

    So the right valuation question is not "is the P/E high?" — it almost always is — but "is the volume growth that justifies this perpetuity actually there, and getting better or worse?" A 50x P/E on a brand quietly losing volume and defending revenue with price is a trap; the same multiple on a brand compounding volume mid-single-digits with premiumisation on top can be fair. The number under the multiple is volume. Which is why, when value growth runs far ahead of volume — Britannia's 6–8% gap through most of FY26 — you should hold the multiple to a higher standard, not a lower one: the market is paying a perpetuity premium for an engine temporarily running on borrowed price.

    A homely way to hold it: a premium FMCG stock is a fixed deposit that quietly raises its own interest rate each year through volume and mix — and the P/E is the price of that compounding promissory note. You're not buying this year's coupon; you're buying the belief that the rate keeps stepping up. The day volume stops rising, the note is just an expensive deposit, and the market re-rates it to one.

    A worked case: Britannia's said-vs-did

    Put the spine to work on one name across one year. (Illustration, not a view on the stock; figures from Inve data unless a concall is cited.)

    In May 2025, asked directly about FY26, Britannia's management committed to the endeavour of returning to "double-digit growth" (Britannia Q4 FY25 concall). A reader who stopped at that line owned a double-digit grower. A reader who pulled the number apart owned something more honest. The very next quarter, management itself laid the gap bare: volume growth of 2% against revenue up 9.8%, with the warning that the volume-to-value delta would persist at "6%, 7%, 8% for the coming 2 or 3 quarters" (Britannia Q1 FY26 concall). The double-digit value aspiration was real; it was being borne almost entirely by price, not by more biscuits sold.

    Now run the metrics forward through the year:

    QuarterRevenue growthVolume growthGross-margin signalWhat management said
    Q4 FY25+9% (Q4)recovering"endeavor… to get back to double digits" (FY26 guidance)
    Q1 FY26+9.8%2%inputs benign"delta between volume and revenue… 6%–8% for 2–3 quarters"
    Q3 FY26+9.5%~half of growth+530 bps GM YoYgrowth "about 50-50" volume and value
    Q4 FY26+7.1%~5.5%margin heldvolume "close to 5.5% upwards"
    FY26 (full year)+7.5%recovered lateOPM ~17%guidance missed (single digit, not double)

    Read it as a sequence, not a snapshot. The FY26 double-digit guidance missed — full-year revenue grew 7.5% (Inve data, Q4 FY26), and the Promise Tracker marks it missed (Inve data). But the more useful read is why and how: the company grew on price for three quarters while volume recovered underneath, then volume came back to ~5.5% by Q4 — supported by a 530 bps gross-margin tailwind from softer inputs (Inve data, Q3 FY26) that flattered the year's optics. The said-vs-did lesson is not "management over-promised." It is that the honest signal lived in the volume line and management's own candid 6–8%-gap comment — both of which told you the double-digit headline was borrowed, a full year before the revenue print confirmed it. That is the gap between watching guidance and watching the metric the guidance rests on. Tracking each forward commitment against what the operating numbers later did — across a 10–15 stock portfolio, quarter after quarter — is the job Inve's Promise Tracker is built for.

    See it on a live earnings call

    Browse AI-analysed concall summaries — guidance tables, graded Q&A, and the quotes behind them — for 1,500+ listed Indian companies.

    Browse concall summaries

    Red flags specific to FMCG

    • A persistent, widening value-over-volume gap. Growth carried by price while volume stalls is borrowed growth that reverses when inflation cools. The single most important tell.
    • Margin "improvement" driven by an A&P cut. Check whether operating-margin gains came from sustained investment or from starving the brand. The latter is a loan against future share.
    • Reach targets that get announced and then vanish. A 450,000-outlet expansion plan that disappears from the next deck (Britannia's ghosted RTM 2.0) was a slide, not a strategy.
    • Gross-margin tailwinds priced as permanent. A margin expanding on cheap inputs is the commodity cycle, not pricing power — it will hand the benefit back via price cuts or grammage.
    • A premium multiple on a brand quietly losing volume. The P/E pays for a perpetuity; if volume isn't compounding, the perpetuity isn't there, and the re-rating down is brutal.

    Frequently asked questions

    The discipline comes down to refusing to be impressed by the revenue line. The income statement blends volume and price into one number on purpose; your job is to pull them apart and ask which one is doing the work. So invert the question you bring to FMCG results. Don't ask "is this a good quarter?" Ask: if this company's brands were quietly losing the habit — fewer units, defended only by price — what would the numbers look like, and does this deck rule that out? A widening value-over-volume gap under a confident revenue guide does not rule it out; it is the pattern itself.

    And the owner's question, the one to sit with before you pay 50 times earnings for a biscuit maker: what must I believe about the next decade of volume — not this quarter's revenue — for this perpetuity to be worth its price? If the honest answer leans on price increases and cheap inputs rather than more people reaching for the brand more often, you have bought the headline, not the business.

    Inve is a research and analysis platform, not an investment adviser. Nothing here is a recommendation to buy or sell any security. Do your own research or consult a SEBI-registered adviser before investing.

    Inve is a research and analysis platform, not an investment adviser. Nothing here is a recommendation to buy or sell any security. Do your own research or consult a SEBI-registered adviser before investing.